Synonyms were used for: cancer • prostate
Search without synonyms: keywords:(metastatic castration-resistant prostate cancer)
Used synonyms:
- bosartiger tumor
- carcinom
- carcinoma
- karzinom
- krebs
- krebserkrankung
- maligner tumor
- malignom
- sarcoma
- sarkom
Used synonyms:
- prostata
- prostatadruse
- prostate gland
- vorsteherdruse
-
Safety and survival of docetaxel and cabazitaxel in metastatic castration-resistant prostate cancer
Free accessDataCite | 2021|Keywords: metastatic castration-resistant prostate cancer -
Treatment-Related Healthcare Costs of Metastatic Castration-Resistant Prostate Cancer in Germany: A Claims Data Study
Free accessDataCite | 2021|Keywords: metastatic castration-resistant prostate cancer (mCRPC) -
Value of Combined PET Imaging with [18F]FDG and [68Ga]Ga-PSMA-11 in mCRPC Patients with Worsening Disease during [177Lu]Lu-PSMA-617 RLT
Free accessBASE | 2021|Keywords: metastatic castration-resistant prostate cancer -
Der DeRitis Quotient als prognostischer Faktor des metastasierten kastrationsresistenten Prostatakarzinoms unter Radioligandentherapie mit 177Lutetium-PSMA
DataCite | 2023|Keywords: metastatic castration-resistant prostate cancer -
Explorative analysis of a score predicting the therapy response of patients with metastatic, castration resistant prostate cancer undergoing radioligand therapy with 177 Lu-labeled prostate-specific membrane antigen
Free accessDataCite | 2020|Keywords: Metastatic castration-resistant prostate cancer -
Early molecular imaging response assessment based on determination of total viable tumor burden in [68Ga]Ga-PSMA-11 PET/CT independently predicts overall survival in [177Lu]Lu-PSMA-617 radioligand therapy
Free accessBASE | 2021|Keywords: Metastatic castration-resistant prostate cancer -
Molecular imaging and biochemical response assessment after a single cycle of [225Ac]Ac-PSMA-617/[177Lu]Lu-PSMA-617 tandem therapy in mCRPC patients who have progressed on [177Lu]Lu-PSMA-617 monotherapy
Free accessBASE | 2021|Keywords: Metastatic castration-resistant prostate cancer -
Der DeRitis Quotient als prognostischer Faktor des metastasierten kastrationsresistenten Prostatakarzinoms unter Radioligandentherapie mit 177Lutetium-PSMA ; The DeRitis ratio as a prognostic factor for metastatic castration-resistant prostate cancer treated with 177Lutetium-PSMA radioligand therapy
Free accessBASE | 2023|Keywords: metastatic castration-resistant prostate cancer -
Efficacy and Safety of [225Ac]Ac-PSMA-617 Augmented [177Lu]Lu-PSMA-617 Radioligand Therapy in Patients with Highly Advanced mCRPC with Poor Prognosis
Free accessBASE | 2021|Keywords: metastatic castration-resistant prostate cancer -
177 Lu-PSMA-617 radioligand therapy of metastatic castration-resistant prostate cancer: Initial 254-patient results from a prospective registry (REALITY Study)
Free accessBASE | 2021|Keywords: Metastatic castration-resistant prostate cancer (mCRPC), Prostate-specifc membrane antigen (PSMA)
Send my search to (beta)
Send your search query (search terms without filters) to other databases, portals and catalogues to find more interesting hits.
Dimensions is a database for abstracts and citations that links information on research funding with the resulting publications, studies and patents.
In the TIB AV-Portal, audiovisual media from science and teaching can be foundand own scientific videos can be published.
The FID move can be used to search for subject-specific literature, research data and other information from mobility and transport research.
The Open Research Knowledge Graph provides structured descriptions of research content and makes it comparable.
Freely accessible part of the collaborative K10plus catalogue with materials relevant for interlibrary loan and direct delivery services.